In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Sure enough, one can't expect a great hammer if their arms are too frail. A simple Club is just about the best bludgeoning weapon available for a level 1 run. The Wretch's base stat barely meets the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results